Addlestone, United Kingdom

Roderick L Hall

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roderick L Hall. Retrieved from https://idiyas.com/inventor/roderick-l-hall

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Roderick L Hall: Innovator in Medicinal Chemistry

Introduction

Roderick L Hall is a notable inventor based in Addlestone, Great Britain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as chloride channel blockers.

Latest Patents

Roderick holds a patent for the "Use of substituted cyclopentane-di- and -triones." This invention pertains to the application of substituted cyclopentane-diones and cyclopentane-triones in the preparation of medicaments. These compounds are particularly effective for controlling airway diseases, secretory diarrhea, and inflammatory diseases.

Career Highlights

Roderick is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to focus on innovative solutions in the healthcare sector.

Collaborations

Roderick has collaborated with notable colleagues, including Peter Norman and Graham A Place. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Roderick L Hall's contributions to medicinal chemistry highlight his role as an innovator in the field. His patent for substituted cyclopentane compounds showcases the potential for new treatments in various medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…